| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 03/18/2010 |
3. Issuer Name and Ticker or Trading Symbol
MANHATTAN PHARMACEUTICALS INC [ MHAN ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock, $0.001 par value per share | 211,568 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Explanation of Responses: |
| Remarks: |
| /s/ Malcolm Morville, By: Michael McGuinness, Attorney-in-Fact | 03/22/2010 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
POWER
OF ATTORNEY FOR DIRECTORS OF
MANHATTAN
PHARMACEUTICALS, INC.
Know all by these presents, that the
undersigned hereby constitutes and appoints Michael McGuinness his true and
lawful attorney-in-fact to:
|
|
1.
|
execute
for and on behalf of the undersigned Form ID, Schedules 13D and 13G, and
Forms 3, 4 and 5 in accordance with Sections 13 and 16(a) of the
Securities Exchange Act of 1934 and the rules
thereunder;
|
|
|
2.
|
do
and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete the execution of any such Form
ID, Schedules 13D or 13G, and Forms 3, 4 or 5 and the timely filing of
such Forms with the United States Securities and Exchange Commission and
any other authority; and
|
|
|
3.
|
take
any other action of any type whatsoever in connection with the foregoing
which, in the opinion of such attorney-in-fact, may be of benefit to, in
the best interest of, or legally required by, the undersigned, including
without limitation the execution and filing of a Form 4 with respect to a
transaction which may be reported on a Form 5, it being understood that
the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may
approve in his/her discretion.
|
The undersigned hereby grants to each
such attorney-in-fact full power and authority to do and perform all and every
act and thing whatsoever requisite, necessary and proper to be done in the
exercise of any of the rights and powers herein granted, as fully and to all
intents and purposes as he might or could do in person, with full power of
substitution and resubstitution, hereby ratifying and confirming all that such
attorney-in-fact, or his/her substitute or substitutes, shall lawfully do or
cause to be done by virtue of this Power of Attorney and the rights and powers
herein granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming any of the undersigned's responsibilities to
comply with Sections 13 or 16 of the Securities Exchange Act of
1934.
IN WITNESS WHEREOF, the undersigned has
caused this Power of Attorney to be executed as of this 18th day of March,
2010.
|
/s/
Malcolm Morville
|
|
|
Name:
Malcolm Morville
|
|
|
A
director of Manhattan Pharmaceuticals,
Inc.
|